Syndax Pharmaceuticals
SNDX
SNDX
115 hedge funds and large institutions have $861M invested in Syndax Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 54 increasing their positions, 31 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less call options, than puts
Call options by funds: $1.31M | Put options by funds: $1.99M
58% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 26
Holders
115
Holding in Top 10
2
Calls
$1.31M
Puts
$1.99M
Top Buyers
| 1 | +$39.9M | |
| 2 | +$14.5M | |
| 3 | +$13.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.3M |
Top Sellers
| 1 | -$23M | |
| 2 | -$22.9M | |
| 3 | -$22.6M | |
| 4 |
VA
VR Adviser
New York
|
-$13.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.9M |